In vivo regulation of ?-opioid receptor density and gene expression in CXBK and outbred Swiss Webster mice
- 1 August 2000
- Vol. 37 (2) , 118-124
- https://doi.org/10.1002/1098-2396(200008)37:2<118::aid-syn6>3.0.co;2-2
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Opioid receptor upregulation in μ-opioid receptor deficient CXBK and outbred Swiss Webster miceLife Sciences, 1999
- Methadone analgesia in morphine-insensitive CXBK miceEuropean Journal of Pharmacology, 1998
- δ and κ Opioid Receptors Are Differentially Regulated by Dynamin-dependent Endocytosis When Activated by the Same Alkaloid AgonistJournal of Biological Chemistry, 1997
- The μ-Opioid Receptor Down-Regulates Differently from the δ-Opioid Receptor: Requirement of a High Affinity Receptor/G Protein Complex FormationMolecular Pharmacology, 1997
- Chronic morphine and naltrexone fail to modify μ-opioid receptor mRNA levels in the rat brainMolecular Brain Research, 1997
- The effect of the irreversible μ-opioid receptor antagonist clocinnamox on morphine potency, receptor binding and receptor mRNAEuropean Journal of Pharmacology, 1995
- Assessment of delta opioid antinociception and receptor mRNA levels in mouse after chronic naltrexone treatmentBrain Research, 1995
- The Effect of Intrinsic Efficacy on Opioid ToleranceAnesthesiology, 1995
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Opiate receptors in mice: Genetic differencesLife Sciences, 1975